EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic, Germany, Italy and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a weekly round up of news relevant to hospital pharmacy in Europe.
You can subscribe to the EAHP EU Monitor here.
The European Association of Hospital Pharmacists (EAHP) reminds its members that there is just one week remaining for hospital pharmacists in practice across Europe to share their experiences of medicines shortages via the current EAHP survey links.
The surveys, launched in the Autumn of 2012, seek responses in relation to both the prevalence of, and the impact upon patient care caused by, shortage problems, and will close at the end of Tuesday 19 February 2013.
Encouraging hospital pharmacy colleagues from across Europe to take part, EAHP President Dr Roberto Frontini said:
“In my time as EAHP President I have heard increasingly concerning reports of the problem of medicines shortages, the increasing time hospital pharmacists must spend seeking to source supply, and the potential impacts this can have on the delivery of patient care. EAHP now wants to compile verifiable evidence of the hospital pharmacist experience of the problem through two short focused surveys.
I hope all hospital pharmacists will have the five minutes required to contribute their experience of medicines shortage difficulties. We also encourage the return of open comments around the issue as all of these are read, taken note of and will be reflected in the final dissemination.
After closing the survey next week, it is our intention to present the results to industry, the European Commission, the European Medicines Agency and other stakeholders to assist their understanding and help to guide their decision-making on how to resolve the problems.”
The survey examining the prevalence of the medicines shortage problem is available to respond to here:
http://www.surveymonkey.com/s/HK5L839
The survey seeking information on the patient impacts of medicines shortages is available to respond to here:
http://www.surveymonkey.com/s/PNBNMTK
Members of the European Parliament have given their support for a 60-day time limit for national authorities to decide on the pricing and reimbursement of generic medicines, in order to speed up their availability and save money for patients and social security systems. 
Decisions concerning new medicines will have to respect the current deadline of 180 days. The Parliament’s report also indicates that national authorities should be required to publish the list of the medicinal products covered by their public health insurance system and their prices at least once a year.
The current European legislative subject file on medicines pricing transparency is designed to be an update of an existing Directive from 1989. However, national governments have so far given a less than enthusiastic response to the proposals, with many countries considering that the requirements infringe the principles of subsidiarity and proportionality.
Negotiations between Governments, the European Parliament and the Commission will continue on the issue.
Report here.
Press release of Antonyia Parvanova (NMSP Bulgaria), the Parliament’s lead rapporteur on the subject, here:
The online first version of the European Journal of Hospital Pharmacy recently published an original research article from the Netherlands on a strategy for development and pre-implementation validation of effective clinical decision support.
The Clinical decision support systems (CDSS) are defined as ‘computer-based information systems used to integrate clinical and patient information to provide support for decision-making in patient care’.
Full article here.
In a special congress preview, session facilitator Dr. Teresa Bermejo Vicedo helps to indicate some of the likely themes of the operational seminar on medication reconciliation.
Preview of seminar here.
Seminar abstract here.
This year’s Congress has the overall theme “Improving patient outcomes: a shared responsibility”
Registration information here.
Information on the Scientific Programme here.
